ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Hunger | 14.03.02.012; 08.01.09.003 | 0.051208% | | Not Available |
Hyperaesthesia | 23.03.03.080; 17.02.06.004 | - | - | Not Available |
Hyperglycaemia | 05.06.02.002; 14.06.02.002 | - | - | |
Hyperhidrosis | 23.02.03.004; 08.01.03.028 | 0.022090% | | |
Hypersensitivity | 10.01.03.003 | - | - | |
Hyperventilation | 22.02.01.006; 19.01.02.004 | - | - | Not Available |
Hypervolaemia | 02.05.04.019; 14.05.06.003 | - | - | Not Available |
Hypoaesthesia | 17.02.06.023; 23.03.03.081 | 0.051208% | | Not Available |
Hypokinesia | 17.01.02.009 | - | - | Not Available |
Hypoxia | 22.02.02.003 | - | - | |
Immune system disorder | 10.02.01.001 | - | - | Not Available |
Impaired gastric emptying | 07.02.02.004 | - | - | |
Impaired healing | 08.03.02.001 | - | - | Not Available |
Incoherent | 19.10.03.006; 17.02.08.002 | - | - | Not Available |
Infertility female | 21.03.02.017 | - | - | Not Available |
Inflammatory bowel disease | 07.08.01.016 | - | - | Not Available |
Influenza like illness | 08.01.03.010 | - | - | |
Injection site bruising | 24.07.06.017; 12.07.03.042; 23.03.11.015; 08.02.03.042 | - | - | Not Available |
Injection site erythema | 12.07.03.001; 08.02.03.001; 23.03.06.015 | 0.670723% | | Not Available |
Injection site haematoma | 24.07.01.009; 12.07.03.004; 08.02.03.004 | - | - | Not Available |
Injection site haemorrhage | 12.07.03.005; 08.02.03.005; 24.07.01.010 | - | - | Not Available |
Injection site hypersensitivity | 12.07.03.006; 10.01.03.017; 08.02.03.006 | - | - | Not Available |
Injection site induration | 12.07.03.007; 08.02.03.007 | 0.068277% | | Not Available |
Injection site infection | 12.07.03.008; 11.01.08.005; 08.02.03.019 | - | - | Not Available |
Injection site inflammation | 12.07.03.009; 08.02.03.008 | - | - | Not Available |
Injection site mass | 12.07.03.010; 08.02.03.009 | 0.175713% | | Not Available |
Injection site necrosis | 12.07.03.020; 08.02.03.020 | - | - | Not Available |
Injection site pain | 12.07.03.011; 08.02.03.010 | 0.341386% | | Not Available |
Injection site pruritus | 12.07.03.014; 08.02.03.013; 23.03.12.007 | 0.238970% | | Not Available |
Injection site rash | 23.03.13.010; 12.07.03.032; 08.02.03.032 | 0.153624% | | Not Available |